Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Change in Accured Expenses: 2009-2024

Historic Change in Accured Expenses for Rockwell Medical (RMTI) over the last 16 years, with Dec 2024 value amounting to -$1.0 million.

  • Rockwell Medical's Change in Accured Expenses fell 140.06% to -$139,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.6 million, marking a year-over-year decrease of 2652.13%. This contributed to the annual value of -$1.0 million for FY2024, which is 175.00% down from last year.
  • According to the latest figures from FY2024, Rockwell Medical's Change in Accured Expenses is -$1.0 million, which was down 175.00% from -$376,000 recorded in FY2023.
  • In the past 5 years, Rockwell Medical's Change in Accured Expenses registered a high of $2.5 million during FY2022, and its lowest value of -$1.0 million during FY2024.
  • In the last 3 years, Rockwell Medical's Change in Accured Expenses had a median value of -$376,000 in 2023 and averaged $374,667.
  • Per our database at Business Quant, Rockwell Medical's Change in Accured Expenses spiked by 5,379.17% in 2022 and then plummeted by 175.00% in 2024.
  • Over the past 5 years, Rockwell Medical's Change in Accured Expenses (Yearly) stood at $534,000 in 2020, then tumbled by 108.99% to -$48,000 in 2021, then surged by 5,379.17% to $2.5 million in 2022, then crashed by 114.84% to -$376,000 in 2023, then crashed by 175.00% to -$1.0 million in 2024.